Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Medication Index

View All
Niravam
Norepinephrine Abbreviations List Factors Influencing Development of Withdrawal Effects Hyperbolic Tapering of Antidepressants Nortriptyline Stratfiying Risk of Antidepressant Withdrawal The Neurobiology of Tapering Vortioxetine When and Why to Stop Gabapentinoids Withdrawal Effects from Psychiatric Medications
Nortriptyline Antidepressants Factors Influencing Development of Withdrawal Effects Nortriptyline Solutions and suspensions Stratfiying Risk of Antidepressant Withdrawal Tapering
Nortriptyline Hydrochloride
Olanzapine
Oxazepam Benzodiazepines Oxazepam Receptor occupancy, Solutions and suspensions Switching to Longer-Acting Benzodiazepines to Taper Tapering Z drugs (benzodiazepine receptor agonists)
OxyContin
Oxytocin
Pamelor
Parnate
Paroxetine
Paxil Paroxetine Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Phenelzine Antidepressants Factors Influencing Development of Withdrawal Effects Moclobemide Phenelzine Solutions and suspensions Stratfiying Risk of Antidepressant Withdrawal Tapering
Phenelzine Sulfate
Pregabalin
Pristiq
Progesterone
Propranolol Further Topics Management of Complications of Benzodiazepine and Z-Drug Discontinuation Management of Complications of Gabapentinoid Discontinuation Managing Complications of Antidepressant Discontinuation Other Considerations in Tapering Benzodiazepines and Z-Drugs Other Considerations in Tapering Gabapentinoids
ProSom
Prozac Fluoxetine The Context for Deprescribing
Quazepam Benzodiazepines Quazepam Receptor occupancy, Solutions and suspensions Switching to Longer-Acting Benzodiazepines to Taper Tapering Z drugs (benzodiazepine receptor agonists)
Remeron
Restoril
Rivotril
Sarafem
Serax
Sertraline
Sinequan
Sodium valproate
SPS